Weekly Mortgage Rate Survey Highlights Benefits of Comparing Lenders Vertical Aerospace EVTL Why the eVTOL Developer Represents a Classic HighRisk Market Play Egypt QatarEnergy ExxonMobil Sign Deal to Route Cypriot Gas to European Markets Summer Electricity Costs Set to Surge as Heat Waves and Rising Rates Collide Nvidia H100 GPU Prices Rise 20 YTD Nebius Group Poised to Benefit from Tight AI Cloud Supply Fanatics Secures FIFA Exclusive Collectibles License Deepening Sports Memorabilia Dominance Simpson Manufacturing Q1 2026 Earnings EPS Surges Past Estimates by 1285 Amid Solid Demand MSAI Q1 2026 Earnings Strong Earnings Beat Drives Share Price Higher Goldman Sachs BDC Inc GSBD Q1 2026 Earnings EPS Miss Weighs on Shares Despite Steady Portfolio Performance NTLA Q1 2026 Earnings NarrowerThanExpected Loss Fuels Optimism in Gene Editing Pipeline UGP Q1 2026 Earnings Strong EPS Beat of 2608 Surprise Stock Slips Slightly Repligen Corporation RGEN Q1 2026 Earnings EPS Surges Past Estimates Revenue Details Not Disclosed Apollomics Inc APLM Declines 317 as Shares Approach Key Support Level CIMN Slips 06 as Investors Assess Support and Resistance Levels MicroCloud Hologram Inc Warrant HOLOW Holds at 008 Stability Amidst Minimal Movement Banzai International Warrant BNZIW Shows Modest Gains Amid LowPriced Trading YXT Stock Edges Higher as Traders Eye Key Resistance Levels NextNRG Inc NXXT Q1 2026 Earnings Loss Narrows Stock Surges on Positive Surprise CXDO Q1 2026 Earnings Strong EPS Beat Drives Positive Investor Sentiment High Templar Tech Limited HTT Q1 2023 Earnings Strong EPS Performance Drives Share Price Rally Halozyme Therapeutics Q1 2026 Earnings EPS Beat Drives Modest Positive Surprise Despite Flat Revenue Disclosure Fox Corporation FOX Q1 2026 Earnings Strong Earnings Beat as EPS Surges Past Estimates CLDT Q1 2026 Earnings Narrowed Loss Beats Estimates Stock Edges Higher B2Gold Corp BTG Strengthens Balance Sheet by Selling Interest in Fingold Ventures AEBI Q1 2026 Earnings EPS Misses Estimates Yet Stock Edges Higher Spero Therapeutics SPRO Hovers Near Support Amid Modest Decline Key Levels in Focus